Tannaz Armaghany, MD

Tannaz Armaghany, MD, discusses the utility of circulating tumor DNA in colorectal cancer.

Tannaz Armaghany, MD, discusses sorafenib versus lenvatinib as first-line therapy for patients with hepatocellular carcinoma.

Tannaz Armaghany, MD, discusses the importance of NCI-MATCH trial in colorectal cancer.

Tannaz Armaghany, MD, discusses up-front gene sequencing in patients with colorectal cancer.